Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lianhua Qingke for treatment of COVID-19
ChiCTR2200064767Phase 4Not yet recruiting
- Sponsor
- Xingtai People's Hospital
- Start
- Oct 2022
- Countries
- 1
01
Overview
Phase 4, randomised trial of Lianhua Qingke in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Xingtai People's Hospital. Primary endpoint: Disappearance rate and median time of clinical symptoms. Planned start Oct 2022; status: not yet recruiting.
02
Drugs
Lianhua Qingke
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ChiCTR2200064767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064767.